Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ascorbic Acid with Gemcitabine and Erlotinib in Metastatic Pancreatic Cancer
NCT01555489Phase 2Terminated
- Sponsor
- Thomas Jefferson University
- Start
- Oct 2011
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ascorbic acid in pancreatic cancer (PC), sponsored by Thomas Jefferson University. Started Oct 2011; status: terminated.
02
Drugs
ascorbic acid
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT01555489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01555489.